首页> 外文期刊>BMC Infectious Diseases >Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study
【24h】

Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study

机译:在完全免疫医疗工作者中,抗生素抗体的长期持续性:意大利回顾队列研究

获取原文
获取外文期刊封面目录资料

摘要

Chickenpox is a highly contagious disease caused by the varicella zoster virus (VZV), and in infants, adolescents, adults, pregnant women, and the immunocompromised it can be serious. The best way to prevent chickenpox is immunization with the varicella vaccine. Protective levels of antibodies induced by the varicella vaccine decline over time, but there is currently no formal recommendation for testing anti-varicella zoster virus (VZV) IgG levels in immunized healthcare workers (HCWs). The aims of this study were to evaluate the seroprevalence of circulating anti-VZV IgG in a sample a sample of students and residents of the medical school of the University of Bari, the long-term immunogenicity of the varicella vaccine, and the effectiveness of a strategy consisting of a third vaccine booster dose. The study population was screened as part of a biological risk assessment conducted between April 2014 and October 2020. A strategy for the management of non-responders was also examined. The 182 students and residents included in the study had a documented history of immunization (two doses of varicella vaccine). The absence of anti-VZV IgG was determined in 34% (62/182; 95%CI?=?27.2–41.4%), with serosusceptibility more common among males than females (p??0.05). After a third varicella dose, seroconversion was achieved in 100% of this previously seronegative group. No serious adverse events were recorded. One-third of the study population immunized against VZV lacked a protective antibody titer, but a third dose of vaccine restored protection. Since it is highly unlikely that VZV will be eliminated in the immediate future, the loss of immunity in a substantial portion of the population implies a risk of varicella outbreaks in the coming years. Screening for varicella immunity in routine assessments of the biological risk of medical students and HCWs may help to prevent nosocomial VZV infections.
机译:水痘是由水痘带状疱疹病毒(VZV)和婴儿,青少年,成年人,孕妇和免疫功能的疾病引起的一种高度传染性疾病。预防水痘的最佳方法是用瓦里氏菌疫苗免疫。水痘疫苗诱导的抗体的保护水平随着时间的推移而下降,但目前没有正式推荐用于检测免疫医疗工作者(HCWS)中的抗生素带状疱疹病毒(VZV)IgG水平。本研究的目的是评估循环抗VZV IgG的SEROPREVALING,在Bari大学医学院的学生和居民样本中,长期免疫原性,以及A的有效性由第三疫苗增压剂组成的策略。该研究人群被筛选为2014年4月至2020年4月至10月20日期间的生物风险评估的一部分。还审查了非响应者管理战略。该研究中包含的182名学生和居民有一个文件的免疫历史(两剂水痘疫苗)。在34%(62/182; 95%CI = 27.2-41.4%)中没有测定抗VZV IgG,血清溶性比女性更常见(P?& 0.05)。在第三种毒液剂量后,在此先前的血清上述基团的100%中达到血清转化。没有记录严重的不良事件。针对VZV免疫的研究人群的三分之一缺乏保护抗体滴度,但第三剂疫苗恢复保护。由于VZV非常不可能在立即将VZV中淘汰,因此大部分人群中的免疫力丧失意味着未来几年毒液爆发的风险。对医学生物生物风险的常规评估中的种子菌免疫筛查可能有助于预防医院VZV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号